Boothbay Fund Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-46,437
| Closed | -$571K | – | 2040 |
|
|
2023
Q2 | $571K | Sell |
46,437
-70,999
| -60% | -$873K | 0.01% | 861 |
|
|
2023
Q1 | $1.44M | Buy |
117,436
+53,225
| +83% | +$654K | 0.03% | 686 |
|
|
2022
Q4 | $736K | Buy |
+64,211
| New | +$736K | 0.02% | 845 |
|
|
2017
Q3 | – | Sell |
-1,766
| Closed | -$17K | – | 800 |
|
|
2017
Q2 | $17K | Buy |
+1,766
| New | +$17K | ﹤0.01% | 562 |
|
|
2016
Q4 | – | Sell |
-1,271
| Closed | -$64K | – | 954 |
|
|
2016
Q3 | $64K | Buy |
+1,271
| New | +$64K | 0.01% | 588 |
|